Tedisamil

This classification denotes an antiarrhythmic agent with the molecular formula C19H32N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) A5VAY2U3R8, chemically known as 3,7-bis(cyclopropylmethyl)spiro(cyclopentane-1,9-(3,7)diazabicyclo(3.3.1)nonane) but more generally known as tedisamil, which bears US NIH Compound Identifier 65825. European Medicines Agency schedules Tedisamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10864MIG. The term TEDISAMIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules tedisamil in its Anatomical Therapeutic Chemical (ATC) Classification. TEDISAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tedisamil under HS 29333999 and SITC 51574. As of Q4 2014, TEDISAMIL remains US FDA's Preferred Term for this commodity. Tedisamil bears US NLM identifiers UMLS ID C0076034 and NCI Concept Code C72585. SMILES: N1(CC2C3(C(C1)CN(C2)CC1CC1)CCCC3)CC1CC1.